118 related articles for article (PubMed ID: 2839581)
1. Prevalence of antibodies to Epstein-Barr virus nuclear antigen 2B in persons infected with the human immunodeficiency virus.
Sculley TB; Cross SM; Borrow P; Cooper DA
J Infect Dis; 1988 Jul; 158(1):186-92. PubMed ID: 2839581
[TBL] [Abstract][Full Text] [Related]
2. Expression of Epstein-Barr virus nuclear antigens 3, 4, and 6 are altered in cell lines containing B-type virus.
Sculley TB; Apolloni A; Stumm R; Moss DJ; Mueller-Lantczh N; Misko IS; Cooper DA
Virology; 1989 Aug; 171(2):401-8. PubMed ID: 2548326
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus nuclear antigens 1 and 2 in Burkitt lymphoma cell lines containing either 'A'- or 'B'-type virus.
Sculley TB; Sculley DG; Pope JH; Bornkamm GW; Lenoir GM; Rickinson AB
Intervirology; 1988; 29(2):77-85. PubMed ID: 2842274
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the serological response in man to the latent membrane protein and the six nuclear antigens encoded by Epstein-Barr virus.
Rowe M; Finke J; Szigeti R; Klein G
J Gen Virol; 1988 Jun; 69 ( Pt 6)():1217-28. PubMed ID: 2838572
[TBL] [Abstract][Full Text] [Related]
5. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases.
Marchini B; Dolcher MP; Sabbatini A; Klein G; Migliorini P
J Autoimmun; 1994 Apr; 7(2):179-91. PubMed ID: 7518683
[TBL] [Abstract][Full Text] [Related]
6. Rat monoclonal antibodies differentiating between the Epstein-Barr virus nuclear antigens 2A (EBNA2A) and 2B (EBNA2B).
Kremmer E; Kranz BR; Hille A; Klein K; Eulitz M; Hoffmann-Fezer G; Feiden W; Herrmann K; Delecluse HJ; Delsol G; Bornkamm GW; Mueller-Lantzsch N; Grässert FA
Virology; 1995 Apr; 208(1):336-42. PubMed ID: 11831716
[TBL] [Abstract][Full Text] [Related]
7. Occurrence of Epstein-Barr virus deoxyribonuclease enzyme activity-neutralizing antibodies. An index of Epstein-Barr virus disease.
Bardy B; Morinet F; Pérol Y
Intervirology; 1989; 30(1):36-43. PubMed ID: 2542178
[TBL] [Abstract][Full Text] [Related]
8. Opportunistic lymphoproliferations associated with Epstein-Barr viral DNA in infants and children with AIDS.
Andiman WA; Eastman R; Martin K; Katz BZ; Rubinstein A; Pitt J; Pahwa S; Miller G
Lancet; 1985 Dec 21-28; 2(8469-70):1390-3. PubMed ID: 2867394
[TBL] [Abstract][Full Text] [Related]
9. Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders.
Birx DL; Redfield RR; Tosato G
N Engl J Med; 1986 Apr; 314(14):874-9. PubMed ID: 3005862
[TBL] [Abstract][Full Text] [Related]
10. Possible role of Epstein-Barr virus infection in cutaneous T-cell lymphomas.
Lee PY; Charley M; Tharp M; Jegasothy BV; Deng JS
J Invest Dermatol; 1990 Sep; 95(3):309-12. PubMed ID: 2166768
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus (EBV) DNA in saliva and EBV serology of HIV-1-infected persons with and without hairy leukoplakia.
Lucht E; Biberfeld P; Linde A
J Infect; 1995 Nov; 31(3):189-94. PubMed ID: 8586837
[TBL] [Abstract][Full Text] [Related]
12. Chronic active Epstein-Barr virus infection, an AIDS-Co-Factor or predominant infection?
McGuire T
Med Hypotheses; 1993 Jan; 40(1):8-14. PubMed ID: 8384286
[TBL] [Abstract][Full Text] [Related]
13. Small noncleaved B cell Burkitt-like lymphoma with chromosome t(8;14) translocation and Epstein-Barr virus nuclear-associated antigen in a homosexual man with acquired immune deficiency syndrome.
Petersen JM; Tubbs RR; Savage RA; Calabrese LC; Proffitt MR; Manolova Y; Manolov G; Shumaker A; Tatsumi E; McClain K
Am J Med; 1985 Jan; 78(1):141-8. PubMed ID: 2981469
[TBL] [Abstract][Full Text] [Related]
14. T cell recognition of Epstein-Barr virus associated lymphomas.
Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
[TBL] [Abstract][Full Text] [Related]
15. Detection of Epstein-Barr virus and genotyping based on EBNA2 protein in Mexican patients with hodgkin lymphoma: a comparative study in children and adults.
Palma I; Sánchez AE; Jiménez-Hernández E; Alvarez-Rodríguez F; Nava-Frias M; Valencia-Mayoral P; Salinas-Lara C; Velazquez-Guadarrama N; Portilla-Aguilar J; Pena RY; Ramos-Salazar P; Contreras A; Alfaro A; Espinosa AM; Nájera N; Gutierrez G; Mejia-Arangure JM; Arellano-Galindo J
Clin Lymphoma Myeloma Leuk; 2013 Jun; 13(3):266-72. PubMed ID: 23276887
[TBL] [Abstract][Full Text] [Related]
16. Antibodies in human sera against the Epstein-Barr virus encoded latent membrane protein (LMP).
Sulitzeanu D; Szigeti R; Hatzubai A; Dillner J; Hammarskjöld ML; Klein G; Klein E
Immunol Lett; 1988 Aug; 18(4):301-6. PubMed ID: 2846438
[TBL] [Abstract][Full Text] [Related]
17. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
Fresen KO; zur Hausen H
Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
[TBL] [Abstract][Full Text] [Related]
18. Studies on cell-mediated immune defects to Epstein-Barr virus and cytomegalovirus in HIV-related disorders.
Sirianni MC; Ragona G; Soddu S; Cuomo L; Aiuti F
Ann N Y Acad Sci; 1987; 511():385-9. PubMed ID: 2830827
[No Abstract] [Full Text] [Related]
19. [Cytotoxicity induced by the serum of patients with AIDS and at high risk of AIDS against cells infected with Epstein-Barr virus].
De la Barrera S; Fejes M; Riera NE; Scaglione C; Pérez Blanco R; de Bracco MM
Rev Argent Microbiol; 1985; 17(3):137-43. PubMed ID: 2829276
[TBL] [Abstract][Full Text] [Related]
20. Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus.
Pearson G; Dewey F; Klein G; Henle G; Henle W
J Natl Cancer Inst; 1970 Nov; 45(5):989-95. PubMed ID: 18605425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
